BIZZARI JEAN-PIERRE 4
4 · PIERIS PHARMACEUTICALS, INC. · Filed Jan 29, 2018
Insider Transaction Report
Form 4
BIZZARI JEAN-PIERRE
Director
Transactions
- Award
Stock Option (right to buy)
2018-01-25+20,000→ 20,000 totalExercise: $7.72Exp: 2028-01-25→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]The stock option will vest in four equal installments on each of March 31, June 30, September 30 and December 31, 2018.